- Home
- PBT vs PHAR Comparison
PBT vs PHAR Comparison
Compare PBT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- PHAR
- Stock Information
- Founded
- PBT 1980
- PHAR 1988
- Country
- PBT United States
- PHAR Netherlands
- Employees
- PBT N/A
- PHAR N/A
- Industry
- PBT Oil & Gas Production
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- PHAR Health Care
- Exchange
- PBT Nasdaq
- PHAR Nasdaq
- Market Cap
- PBT 599.9M
- PHAR 627.5M
- IPO Year
- PBT N/A
- PHAR N/A
- Fundamental
- Price
- PBT $11.71
- PHAR $9.93
- Analyst Decision
- PBT
- PHAR Strong Buy
- Analyst Count
- PBT 0
- PHAR 3
- Target Price
- PBT N/A
- PHAR $27.00
- AVG Volume (30 Days)
- PBT 198.6K
- PHAR 5.8K
- Earning Date
- PBT 01-01-0001
- PHAR 03-13-2025
- Dividend Yield
- PBT 4.68%
- PHAR N/A
- EPS Growth
- PBT 25.21
- PHAR N/A
- EPS
- PBT 0.78
- PHAR N/A
- Revenue
- PBT $37,735,284.00
- PHAR $285,745,000.00
- Revenue This Year
- PBT N/A
- PHAR $20.08
- Revenue Next Year
- PBT N/A
- PHAR $9.22
- P/E Ratio
- PBT $15.09
- PHAR N/A
- Revenue Growth
- PBT 25.46
- PHAR 30.64
- 52 Week Low
- PBT $10.14
- PHAR $6.65
- 52 Week High
- PBT $15.79
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- PBT 49.58
- PHAR 56.34
- Support Level
- PBT $11.48
- PHAR $9.14
- Resistance Level
- PBT $12.00
- PHAR $10.15
- Average True Range (ATR)
- PBT 0.51
- PHAR 0.62
- MACD
- PBT 0.09
- PHAR -0.09
- Stochastic Oscillator
- PBT 80.16
- PHAR 42.13
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.